Stockreport

Yellowstone Biosciences launches with £16.5 million to pioneer soluble bispecific TCR-based therapies for cancer [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Spun out of the University of Oxford from the pioneering work of Professor Paresh Vyas, initially starting in acute myeloid leukaemia (AML) with broader pipeline potent [Read more]